| Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control. | Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control.
Lin T, Pu X, Zhou S, Huang Z, Chen Q, Zhang Y, Mao Q, Liang Y, Ding G. | 11/22/2023 |
| MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression. | MiR-484 promotes the malignant progression of glioma by inhibiting CDKN2A expression.
Gu Y, Lei H, Ma P, Chen Y. | 10/12/2023 |
| Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression. | Long Non-Coding RNA BCAR4 Promotes Oxaliplatin Resistance in Colorectal Cancer by Modulating miR-484-3p/RAB5C Expression.
Li X, Chen X, Fu C, Xie M, Ouyang S. | 09/14/2023 |
| Mir-484 contributes to diminished ovarian reserve by regulating granulosa cell function via YAP1-mediated mitochondrial function and apoptosis. | Mir-484 contributes to diminished ovarian reserve by regulating granulosa cell function via YAP1-mediated mitochondrial function and apoptosis.
Li H, Wang X, Mu H, Mei Q, Liu Y, Min Z, Zhang L, Su P, Xiang W., Free PMC Article | 04/23/2022 |
| Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. | Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.
Zhao Z, Shuang T, Gao Y, Lu F, Zhang J, He W, Qu L, Chen B, Hao Q. | 03/12/2022 |
| The Downregulation of lncRNA pgm5-as1 Inhibits the Proliferation and Metastasis Via Increasing miR-484 Expression in Colorectal Cancer. | The Downregulation of lncRNA pgm5-as1 Inhibits the Proliferation and Metastasis Via Increasing miR-484 Expression in Colorectal Cancer.
Shen Y, Qi L, Li Y, Zhang Y, Gao X, Zhu Y, Wang K. | 10/23/2021 |
| miR-484: A Possible Indicator of Drug-Induced Pulmonary Fibrosis. | miR-484: A Possible Indicator of Drug-Induced Pulmonary Fibrosis.
Konaka T, Kawami M, Yamamoto A, Yumoto R, Takano M. | 10/2/2021 |
| miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers. | miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers.
Wei Y, Li H, Qu Q. | 06/26/2021 |
| 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations. | 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations.
Allach El Khattabi L, Heide S, Caberg JH, Andrieux J, Doco Fenzy M, Vincent-Delorme C, Callier P, Chantot-Bastaraud S, Afenjar A, Boute-Benejean O, Cordier MP, Faivre L, Francannet C, Gerard M, Goldenberg A, Masurel-Paulet A, Mosca-Boidron AL, Marle N, Moncla A, Le Meur N, Mathieu-Dramard M, Plessis G, Lesca G, Rossi M, Edery P, Delahaye-Duriez A, De Pontual L, Tabet AC, Lebbar A, Suiro L, Ioos C, Natiq A, Chafai Elalaoui S, Missirian C, Receveur A, François-Fiquet C, Garnier P, Yardin C, Laroche C, Vago P, Sanlaville D, Dupont JM, Benzacken B, Pipiras E. | 06/12/2021 |
| miR-484 is associated with disease recurrence and promotes migration in prostate cancer. | miR-484 is associated with disease recurrence and promotes migration in prostate cancer.
Lee D, Tang W, Dorsey TH, Ambs S., Free PMC Article | 04/3/2021 |
| Long noncoding RNA PVT1 promotes metastasis via miR-484 sponging in osteosarcoma cells. | Long noncoding RNA PVT1 promotes metastasis via miR-484 sponging in osteosarcoma cells.
Yan M, Pan XF, Liu Y, Zhao S, Gong WQ, Liu W. | 03/20/2021 |
| MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18. | MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18.
Liu J, Li SM., Free PMC Article | 03/6/2021 |
| Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study. | Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
Holubekova V, Kolkova Z, Grendar M, Brany D, Dvorska D, Stastny I, Jagelkova M, Zelinova K, Samec M, Liskova A, Laucekova Z, Kudela E, Bobrovska M, Kalman M, Zubor P, Dankova Z., Free PMC Article | 02/27/2021 |
| lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP. | lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP.
Li N, Yang G, Luo L, Ling L, Wang X, Shi L, Lan J, Jia X, Zhang Q, Long Z, Liu J, Hu W, He Z, Liu H, Liu W, Zheng G. | 01/23/2021 |
| Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer. | Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer.
Li Y, Liu Y, Yao J, Li R, Fan X., Free PMC Article | 12/5/2020 |
| Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer. | Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W, Su X, Li S, Liu Z, Wang Q, Zeng H. | 12/5/2020 |
| we show that these effects are probably caused by direct miRNA/mRNA interaction, which are reversible by Pax-5 recombinant expression. Interestingly, miRNAs 484 and 210, which are both overexpressed in clinical tumor samples, are also modulated during epithelial-mesenchymal transitioning and hypoxia that correlate inversely to Pax-5 expression. | miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J, LeBlanc N, Ouellette RJ, Robichaud GA. | 05/9/2020 |
| Nucleolin (NCL) is a major regulator of miR processing in response to OS and essential for the maturation of miR-93 and miR-484 that target mRNAs encoding KLF2 and eNOS. AMPK phosphorylation of NCL sequesters it in the nucleus, thereby inhibiting miR-93 and miR-484 processing and their subsequent targeting of KLF2 and eNOS mRNA. Elevated levels of miR-93 and miR-484 were found in sera of coronary artery disease patients. | Shear stress regulation of miR-93 and miR-484 maturation through nucleolin.
Gongol B, Marin T, Zhang J, Wang SC, Sun W, He M, Chen S, Chen L, Li J, Liu JH, Martin M, Han Y, Kang J, Johnson DA, Lytle C, Li YS, Huang PH, Chien S, Shyy JY., Free PMC Article | 04/11/2020 |
| circADAMTS13 can serve as a tumor suppressor during hepatocellular carcinoma progression via the functional pathway of sponging miR-484. | Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.
Qiu L, Huang Y, Li Z, Dong X, Chen G, Xu H, Zeng Y, Cai Z, Liu X, Liu J., Free PMC Article | 12/21/2019 |
| The miR-484/TUSC5 is potential diagnostic biomarkers and therapy targets for Hepatocellular carcinoma (HCC). | Dysregulation of miR484-TUSC5 axis takes part in the progression of hepatocellular carcinoma.
Wang S, Wang W, Han X, Wang Y, Ge Y, Tan Z. | 09/7/2019 |
| The study suggested that ZFAS1 could act as an oncogene in colorectal cancer tumorigenesis, and discovered the functional regulatory pathway of ZFAS1 sponging miR-484. | Long non-coding RNA ZFAS1 sponges miR-484 to promote cell proliferation and invasion in colorectal cancer.
Xie S, Ge Q, Wang X, Sun X, Kang Y., Free PMC Article | 08/31/2019 |
| study suggests that miR-484 and MAP2 can be utilized as predictors for the clinical diagnosis and prognosis of glioma | miR-484/MAP2/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1/2 signaling.
Yi R, Feng J, Yang S, Huang X, Liao Y, Hu Z, Luo M. | 09/8/2018 |
| MiR-484 accelerated the non-small-cell lung cancer cell progression associated with the inhibition of apoptosis. | MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis.
Li T, Ding ZL, Zheng YL, Wang W. | 07/28/2018 |
| miR-155 and miR-484 are potentially connected with sunitinib resistance and failure of the therapy. miR-155 is a known oncogene with direct influence on neovascularization. Biological role of miR-484 has to be clarified. | miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib.
Merhautova J, Hezova R, Poprach A, Kovarikova A, Radova L, Svoboda M, Vyzula R, Demlova R, Slaby O., Free PMC Article | 03/12/2016 |
| miR-484-modulated cytidine deaminase has a dual impact in promoting chemoresistance and suppressing cell proliferation in breast cancer | Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.
Ye FG, Song CG, Cao ZG, Xia C, Chen DN, Chen L, Li S, Qiao F, Ling H, Yao L, Hu X, Shao ZM. | 01/30/2016 |